>
Switch to:

Cullinan Oncology EV-to-EBIT

: (As of Today)
View and export this data going back to 2021. Start your Free Trial

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Cullinan Oncology's Enterprise Value is $582.89 Mil. Cullinan Oncology does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in Dec. 2019. Therefore, GuruFocus does not calculate Cullinan Oncology's EV-to-EBIT at this moment.

The historical rank and industry rank for Cullinan Oncology's EV-to-EBIT or its related term are showing as below:

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Cullinan Oncology's Enterprise Value for the quarter that ended in Dec. 2019 was $0.00 Mil. Cullinan Oncology does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in Dec. 2019. Therefore, GuruFocus does not calculate Cullinan Oncology's Earnings Yield (Joel Greenblatt) % at this moment.


Cullinan Oncology EV-to-EBIT Historical Data

The historical data trend for Cullinan Oncology's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cullinan Oncology Annual Data
Trend Dec18 Dec19 Dec20
EV-to-EBIT
- - -

Cullinan Oncology Semi-Annual Data
Dec18 Dec19 Dec20
EV-to-EBIT - - -

Competitive Comparison

For the Biotechnology subindustry, Cullinan Oncology's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Cullinan Oncology EV-to-EBIT Distribution

For the Biotechnology industry and Healthcare sector, Cullinan Oncology's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Cullinan Oncology's EV-to-EBIT falls into.



Cullinan Oncology EV-to-EBIT Calculation

Cullinan Oncology's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=582.885/
=


Cullinan Oncology  (NAS:CGEM) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Cullinan Oncology's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2019 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2019 ) =EBIT / Enterprise Value (Q: Dec. 2019 )
=/0
= %


Cullinan Oncology EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Cullinan Oncology's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Cullinan Oncology Business Description

Cullinan Oncology logo
Industry
Healthcare » Biotechnology NAICS : 541713 SIC : 2834
Comparable Companies
Traded in Other Exchanges
N/A
Address
One Main Street, Suite 520, Cambridge, MA, USA, 02142
Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients.

Cullinan Oncology Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)